New combo treatment aims to cut blood transfusions in bone cancer surgery
Disease control
Not yet recruiting
This study is testing whether giving patients with low iron or anemia a combination of intravenous iron, a hormone (EPO), and a bleeding-reducing drug before bone tumor surgery can improve their blood counts and reduce the need for blood transfusions. It will involve 160 adults w…
Phase: PHASE4 • Sponsor: Tang Xiaodong • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC